Ferring USA adds two new products to fertility portfolio
The Pharma Letter

Ferring USA adds two new products to fertility portfolio

Privately-held Swiss drugmaker Ferring Pharmaceuticals has agreed terms to acquire the US commercialization rights for a generic version of ganirelix acetate, a